undamentalytics Newsletter

Concord Medical Services Holdings Ltd income statement

In fiscal 2025, Concord Medical Services Holdings Ltd reported revenue of $64.1m, up 20.1% on the year before, operating income of −$36.4m (a -56.8% margin) and net income of −$12.9m, or −$2.96 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Concord Medical Services Holdings Ltd: income statement, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue4358707292989869492929327570765364
Cost of revenue1318252635455643342631308493876460
Gross profit3039454656544225153−22−9−23−11−114
General and administrative41012101492131354446435446475630
Operating income2527−25292530−1−25−31−45−63−46−71−78−65−74−36
Interest expense1112698131374121118232721
Income before tax2426−26292329−1313834576482−125−79−93−52
Income tax5679101312955−6−5−1−11−3−21
Net income719−33211420−12−39−42−36−44−45−42−73−42−43−13
Diluted EPS—$3.94−$7.01$4.52$3.12$4.48−$2.77−$9.04−$9.73————−$16.71−$9.62−$9.80−$2.96
Diluted shares (average)—5m5m5m5m5m4m4m4m4m4m4m4m4m4m4m4m
EBITDA3239−1048505821−8−19−39−57−38−61−65−54−62−22

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CCM vs NIVFBMGL vs CCMCCM vs SNDA

More: Health Care Facilities stocks compared, Health Care sector, rankings of US companies

Figures from Concord Medical Services Holdings Ltd's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Concord Medical Services Holdings Ltd.